Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system

Toshiro Matsui, Kei Tamaya, Eiji Seki, Katsuhiro Osajima, Kiyoshi Matsumoto, Terukazu Kawasaki

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

1. Intact absorption of the bioactive dipeptide Val-Tyr (VY), with in vivo antihypertensive ability in normotensive human subjects, was investigated. 2. As a result of a single oral administration of VY, the VY absorption curve occurred maximally over the second hour postprandially; a greater than 10-fold higher increment of VY following a dose of 12 mg was observed in the plasma at 2 h compared with the baseline concentration of VY at 0 h (1934 ± 145 vs 159 ± 11 fmol/mL plasma, respectively). 3. Plasma VY levels increased with dose administered (3, 6 and 12 mg), suggesting that exogenous VY could be absorbed intact into the human blood depending on the dose. The elimination half time (t1/2) of VY was estimated to be 3.1 h. The area under the curve for the 12 mg VY dose was 9185 ± 688 fmol·h/mL plasma.

Original languageEnglish
Pages (from-to)204-208
Number of pages5
JournalClinical and Experimental Pharmacology and Physiology
Volume29
Issue number3
DOIs
Publication statusPublished - 2002

Fingerprint

valyltyrosine
Dipeptides
Cardiovascular System
Antihypertensive Agents
Area Under Curve
Oral Administration

All Science Journal Classification (ASJC) codes

  • Physiology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system. / Matsui, Toshiro; Tamaya, Kei; Seki, Eiji; Osajima, Katsuhiro; Matsumoto, Kiyoshi; Kawasaki, Terukazu.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 29, No. 3, 2002, p. 204-208.

Research output: Contribution to journalArticle

Matsui, Toshiro ; Tamaya, Kei ; Seki, Eiji ; Osajima, Katsuhiro ; Matsumoto, Kiyoshi ; Kawasaki, Terukazu. / Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system. In: Clinical and Experimental Pharmacology and Physiology. 2002 ; Vol. 29, No. 3. pp. 204-208.
@article{b736a2118ba147d3a5b29de1d8691004,
title = "Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system",
abstract = "1. Intact absorption of the bioactive dipeptide Val-Tyr (VY), with in vivo antihypertensive ability in normotensive human subjects, was investigated. 2. As a result of a single oral administration of VY, the VY absorption curve occurred maximally over the second hour postprandially; a greater than 10-fold higher increment of VY following a dose of 12 mg was observed in the plasma at 2 h compared with the baseline concentration of VY at 0 h (1934 ± 145 vs 159 ± 11 fmol/mL plasma, respectively). 3. Plasma VY levels increased with dose administered (3, 6 and 12 mg), suggesting that exogenous VY could be absorbed intact into the human blood depending on the dose. The elimination half time (t1/2) of VY was estimated to be 3.1 h. The area under the curve for the 12 mg VY dose was 9185 ± 688 fmol·h/mL plasma.",
author = "Toshiro Matsui and Kei Tamaya and Eiji Seki and Katsuhiro Osajima and Kiyoshi Matsumoto and Terukazu Kawasaki",
year = "2002",
doi = "10.1046/j.1440-1681.2002.03628.x",
language = "English",
volume = "29",
pages = "204--208",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system

AU - Matsui, Toshiro

AU - Tamaya, Kei

AU - Seki, Eiji

AU - Osajima, Katsuhiro

AU - Matsumoto, Kiyoshi

AU - Kawasaki, Terukazu

PY - 2002

Y1 - 2002

N2 - 1. Intact absorption of the bioactive dipeptide Val-Tyr (VY), with in vivo antihypertensive ability in normotensive human subjects, was investigated. 2. As a result of a single oral administration of VY, the VY absorption curve occurred maximally over the second hour postprandially; a greater than 10-fold higher increment of VY following a dose of 12 mg was observed in the plasma at 2 h compared with the baseline concentration of VY at 0 h (1934 ± 145 vs 159 ± 11 fmol/mL plasma, respectively). 3. Plasma VY levels increased with dose administered (3, 6 and 12 mg), suggesting that exogenous VY could be absorbed intact into the human blood depending on the dose. The elimination half time (t1/2) of VY was estimated to be 3.1 h. The area under the curve for the 12 mg VY dose was 9185 ± 688 fmol·h/mL plasma.

AB - 1. Intact absorption of the bioactive dipeptide Val-Tyr (VY), with in vivo antihypertensive ability in normotensive human subjects, was investigated. 2. As a result of a single oral administration of VY, the VY absorption curve occurred maximally over the second hour postprandially; a greater than 10-fold higher increment of VY following a dose of 12 mg was observed in the plasma at 2 h compared with the baseline concentration of VY at 0 h (1934 ± 145 vs 159 ± 11 fmol/mL plasma, respectively). 3. Plasma VY levels increased with dose administered (3, 6 and 12 mg), suggesting that exogenous VY could be absorbed intact into the human blood depending on the dose. The elimination half time (t1/2) of VY was estimated to be 3.1 h. The area under the curve for the 12 mg VY dose was 9185 ± 688 fmol·h/mL plasma.

UR - http://www.scopus.com/inward/record.url?scp=0036126473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036126473&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1681.2002.03628.x

DO - 10.1046/j.1440-1681.2002.03628.x

M3 - Article

C2 - 11906484

AN - SCOPUS:0036126473

VL - 29

SP - 204

EP - 208

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 3

ER -